Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Burkitt Lymphoma 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Leukemia, Biphenotypic, Acute 8Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 5Leukemia, Myeloid, Acute 5Leukemia, Myeloid, Accelerated Phase 4Blast Crisis 4Down Syndrome 3Myelodysplastic Syndromes 2Lymphoma, Mantle-Cell 2Blastic Plasmacytoid Dendritic Cell Neoplasm 2Urinary Bladder Neoplasms 1Renal Pelvis and Ureter Urothelial Carcinoma 1Primary Myelofibrosis 1Osteosarcoma 1Oropharyngeal Neoplasms 1Myelodysplastic-Myeloproliferative Diseases 1Mouth Neoplasms 1Medulloblastoma 1Lymphoma 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Hematopoietic and Lymphatic System Neoplasm 1Head and Neck Neoplasms 1Carcinoma 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Specimen Handling 2Biopsy 2pembrolizumab 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1merphos 1enfortumab vedotin 1durvalumab 1Vinblastine 1Platinum 1Nephroureterectomy 1Methotrexate 1Magnetic Resonance Spectroscopy 1Immunoglobulin G 1Gemcitabine 1Doxorubicin 1Disulfides 1Cisplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Renal Pelvis and Ureter Urothelial Carcinoma × merphos × 1 year × Clear all
NCT04628767 2026-06-03

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

National Cancer Institute (NCI)

Phase 2/3 Recruiting
131 enrolled
Genitourinary

Renal Pelvis and Ureter Urothelial Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡